compounding glp-1 fda New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our FDA is moving to restrict
Description
Understanding the connection between GLP-1 therapy and insomnia helps you recognize symptoms and work with your provider to adjust your approach
Medicare Part D legally cannot cover GLP-1s for weight loss

Discover Empower Pharmacy's recent price reductions on GLP-1 medications and hormone replacement therapies, making quality healthcare more accessible.
HPLC verified, COA included with every batch

Your promise: Start seeing results within days, not months
